• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 5. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives 3-hydroxysteroids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Hydroxysteroids 3-hydroxysteroids

Research Brief on (3β)-24-Bromochol-5-en-3-ol (CAS: 74041-57-9): Recent Advances and Applications

The compound (3β)-24-Bromochol-5-en-3-ol (CAS: 74041-57-9) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and emerging roles in drug discovery and development.

Recent studies have highlighted the importance of (3β)-24-Bromochol-5-en-3-ol as a key intermediate in the synthesis of steroidal compounds with diverse pharmacological activities. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its utility in the development of novel cholesterol-modulating agents, leveraging its brominated side chain for targeted interactions with enzymes involved in cholesterol biosynthesis. The compound's ability to selectively inhibit specific enzymatic pathways has positioned it as a promising candidate for treating hypercholesterolemia and related metabolic disorders.

In addition to its metabolic applications, (3β)-24-Bromochol-5-en-3-ol has shown potential in oncology research. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported its efficacy as a precursor for synthesizing steroidal analogs with cytotoxic activity against certain cancer cell lines. The bromine atom at the 24-position was found to enhance the compound's binding affinity to tumor-specific receptors, suggesting a mechanism for its selective toxicity. These findings underscore the compound's versatility in drug design, particularly in the development of targeted therapies.

From a synthetic chemistry perspective, advancements in the scalable production of (3β)-24-Bromochol-5-en-3-ol have been achieved through optimized bromination protocols and green chemistry approaches. Researchers have developed more efficient methods for introducing the bromine moiety while minimizing byproducts, as detailed in a recent Organic Process Research & Development article (2024). These improvements are critical for ensuring the compound's availability for large-scale preclinical and clinical studies.

Looking ahead, the unique structural features of (3β)-24-Bromochol-5-en-3-ol continue to inspire innovative applications. Ongoing research is exploring its potential in neurodegenerative diseases, where its steroidal backbone may interact with neuronal membranes to modulate protein aggregation. Furthermore, computational studies are being conducted to predict its interactions with additional biological targets, which could expand its therapeutic scope. The compound's multifaceted roles highlight its significance as a valuable tool in both basic research and applied pharmaceutical development.

In conclusion, (3β)-24-Bromochol-5-en-3-ol (CAS: 74041-57-9) represents a compelling case study in the intersection of chemical synthesis and biological activity. Its recent applications in metabolic disorders, oncology, and beyond demonstrate the enduring relevance of steroidal compounds in modern drug discovery. As synthetic methodologies advance and biological insights deepen, this compound is poised to contribute further to the development of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)